Trinity Biotech PLC

TRIB

Company Profile

  • Business description

    Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

  • Contact

    IDA Business Park
    Bray, County Wicklow
    DublinA98 H5C8
    IRL

    T: +353 12769800

    E: [email protected]

    https://www.trinitybiotech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    401

Stocks News & Analysis

stocks

WiseTech result disappoints, but the future looks bright

Markets appear underwhelmed by recent sales growth, however, our kingmaker thesis is intact.
stocks

WOW earnings: Woolworths losing market share, but will catch up to Coles

Woolworths have had a soft start to a challenging year, but Morningstar analyst believes it will eventually catch up to its main competitor.
stocks

Chart of the Week: Largest share price falls during earnings

Opportunities arise when the market overreacts, and good quality companies are mispriced.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,241.100.50-0.01%
CAC 407,762.6018.670.24%
DAX 4024,039.926.29-0.03%
Dow JONES (US)45,573.147.910.02%
FTSE 1009,216.8238.68-0.42%
HKSE24,998.82202.94-0.81%
NASDAQ21,700.56110.420.51%
Nikkei 22542,828.79308.520.73%
NZX 50 Index12,903.0841.240.32%
S&P 5006,495.7614.360.22%
S&P/ASX 2008,980.009.500.11%
SSE Composite Index3,843.6043.251.14%

Market Movers